PhosImmune's Seed VC Round

PhosImmune raised a round of funding on August 12, 2014. Investors include CIT GAP Funds.

PhosImmune is a cancer immunotherapy company that was founded to commercialize a library of phosphopeptide tumor targets (PTTs) discovered at the University of Virginia and the University of Birmingha…

Articles about PhosImmune's Seed VC Round: